Clinical Updates

Scientists at Dana-Farber Cancer Institute and colleagues overseas have discovered a pair of backup circuits in cancer cells that enable… »   

Drugs produced in offshore manufacturing plants –- even those run by U.S. manufacturers—pose a greater quality risk than those prepared… »   

One of the holy grails in diabetes research is to discover molecules that stimulate beta cell growth and to find… »   

More and more American adolescents are getting recommended vaccines, according to a survey by the Centers for Disease Control and… »   

Researchers at Albert Einstein College of Medicine of Yeshiva University report in the September 4 online edition of Nature Medicine… »   

An experimental stroke preventer from Bayer and Johnson & Johnson is likely to win a recommendation from U.S. health advisers… »   

U.S. regulators and the drug industry want to extend by two months the deadline for the Food and Drug Administration… »   

The FDA has approved Gilead’s Complera, the second complete HIV treatment in a single, once-daily pill.

Complera is a combination… »   

The FDA today approved Zelboraf, a drug that can extend survival for the 50% of melanoma patients whose tumors carry… »   

The FDA has approved the drug Adcetris to treat two types of lymphoma, Hodgkin’s lymphoma and a rare type of… »   

The FDA says it has approved Anascorp as the first specific treatment to counteract the sometimes dangerous or even fatal… »   

An analysis of 30,000-year-old bacteria whose DNA has been recovered from the Yukon permafrost shows that they were able to… »   

After two days of discussion and testimony about silicone breast implants, a top government health official said he had heard… »   

An investigation into the mysterious inner workings of the malaria parasite has revealed that it survives and proliferates in the… »   

Pfizer Inc.‘s just-approved drug Xalkori, the first new medicine in more than six years for deadly lung cancer, proves the… »